# OnCo record rejuv-recovery-matrix (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-recovery-matrix/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-recovery-matrix" ;
  schema:name "What comes back after treatment, treatment by treatment"@en ;
  schema:description "For each treatment and each lasting effect, whether recovery is usual, partial or unlikely, how long it takes and in what proportion of people, with the source for every answer. The grid is mostly empty, because for most pairs nobody has published a recovery figure, and the page says how empty it is rather than hiding it."@en ;
  schema:url <https://onco.cc/technologies/rejuv-recovery-matrix/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cancer_survivor> ;
  schema:citation <https://doi.org/10.1016/j.pain.2014.09.020>, <https://doi.org/10.1161/CIRCULATIONAHA.114.013777>, <https://doi.org/10.1007/s00520-021-06502-4> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "evidence:strong", "late-effects" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cardiotoxicity-surveillance-recovery/>, <https://onco.cc/technologies/cipn-recovery-and-treatment/>, <https://onco.cc/technologies/hearing-after-platinum-chemotherapy/>, <https://onco.cc/technologies/cancer-treatment-bone-loss/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/cognitive-impairment-after-cancer-treatment/>, <https://onco.cc/technologies/rejuv-recovery-endocrine-permanence/>, <https://onco.cc/technologies/rejuv-recovery-cumulative-dose/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:terms <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/quality-of-life/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> .